NorthCoast Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

NorthCoast Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.49M	Sell	75,737 -3,729	-5%	-$246K	0.16%	114
2021 Q2	$5.31M	Buy	79,466 +28,230	+55%	+$1.84M	0.19%	107
2021 Q1	$3.23M	Buy	51,236 +34,747	+211%	+$2.16M	0.13%	128
2020 Q4	$1.02M	Buy	16,489 +3,970	+32%	+$244K	0.05%	203
2020 Q3	$755K	Buy	12,519 +8,063	+181%	+$485K	0.04%	213
2020 Q2	$262K	Buy	4,456 +39	+0.9%	+$2.33K	0.01%	300
2020 Q1	$246K	Sell	4,417 -22,862	-84%	-$1.4M	0.02%	292
2019 Q4	$1.75M	Sell	27,279 -418	-2%	-$23.9K	0.11%	114
2019 Q3	$1.41M	Sell	27,697 -304	-1%	-$14.3K	0.09%	126
2019 Q2	$1.27M	Sell	28,001 -935	-3%	-$43.6K	0.08%	135
2019 Q1	$1.38M	Sell	28,936 -2,952	-9%	-$147K	0.09%	131
2018 Q4	$1.66M	Buy	31,888 +10,635	+50%	+$571K	0.13%	104
2018 Q3	$1.32M	Sell	21,253 -16,971	-44%	-$1.01M	0.08%	142
2018 Q2	$2.12M	Buy	+38,224	New	+$2.06M	0.2%	73
2018 Q1	–	Sell	-10,008	Closed	-$613K	–	173
2017 Q4	$613K	Buy	+10,008	New	+$626K	0.06%	157

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NorthCoast Asset Management's BMY Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q3 2021, selling an estimated $246K and leaving 75,737 shares worth $4.49M. The position accounts for 0.16% of the portfolio, ranked #114.

NorthCoast Asset Management first reported a position in BMY in Q4 2017 and has held it in 15 quarters since. The position peaked at $5.31M in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

NorthCoast Asset Management held 75,737 shares of Bristol-Myers Squibb worth $4.49M as of Q3 2021.
NorthCoast Asset Management sold 3,729 Bristol-Myers Squibb shares in Q3 2021, an estimated $246K.
Bristol-Myers Squibb made up 0.16% of NorthCoast Asset Management's portfolio in Q3 2021, its #114 holding.
NorthCoast Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 15 quarters since.
NorthCoast Asset Management's Bristol-Myers Squibb position peaked at $5.31M in Q2 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.